3 news items
Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
ALBT
24 May 24
") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced that it received a notice
La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors
ALBT
BICX
LRHC
21 May 24
commitment to innovation align perfectly with our goals, and we expect that her contributions will be instrumental in achieving our long-term objectives
Avalon GloboCare Extends Exclusivity Agreement To Distribute KetoAir Breathalyzer Device And AI-Enabled Software In North America, South America, United Kingdom And European Union
ALBT
28 Mar 24
") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, is pleased to announce
- Prev
- 1
- Next